Wedbush Securities’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-7,020
| Closed | -$36K | – | 961 |
|
|
2020
Q3 | $36K | Buy |
7,020
+4,962
| +241% | +$32.7K | ﹤0.01% | 901 |
|
|
2020
Q2 | $14K | Sell |
2,058
-16
| -0.8% | -$105 | ﹤0.01% | 948 |
|
|
2020
Q1 | $10K | Sell |
2,074
-12
| -0.6% | -$105 | ﹤0.01% | 873 |
|
|
2019
Q4 | $19K | Sell |
2,086
-2,031
| -49% | -$14.1K | ﹤0.01% | 984 |
|
|
2019
Q3 | $30K | Buy |
4,117
+779
| +23% | +$6.34K | ﹤0.01% | 963 |
|
|
2019
Q2 | $42K | Sell |
3,338
-1,011
| -23% | -$11.6K | ﹤0.01% | 956 |
|
|
2019
Q1 | $44K | Buy |
4,349
+1,075
| +33% | +$11.7K | ﹤0.01% | 898 |
|
|
2018
Q4 | $30K | Buy |
3,274
+1,973
| +152% | +$32.7K | ﹤0.01% | 807 |
|
|
2018
Q3 | $31K | Buy |
1,301
+614
| +89% | +$20.2K | ﹤0.01% | 880 |
|
|
2018
Q2 | $54K | Sell |
687
-584
| -46% | -$48.3K | 0.01% | 837 |
|
|
2018
Q1 | $109K | Sell |
1,271
-173
| -12% | -$23.1K | 0.01% | 750 |
|
|
2017
Q4 | $180K | Sell |
1,444
-50
| -3% | -$6.33K | 0.02% | 733 |
|
|
2017
Q3 | $224K | Sell |
1,494
-169
| -10% | -$21.3K | 0.03% | 661 |
|
|
2017
Q2 | $197K | Buy |
1,663
+155
| +10% | +$25.9K | 0.03% | 709 |
|
|
2017
Q1 | $299K | Buy |
1,508
+779
| +107% | +$148K | 0.04% | 538 |
|
|
2016
Q4 | $197K | Buy |
729
+459
| +170% | +$149K | 0.03% | 669 |
|
|
2016
Q3 | $107K | Sell |
270
-122
| -31% | -$50.2K | 0.02% | 746 |
|
|
2016
Q2 | $136K | Buy |
392
+119
| +44% | +$85.2K | 0.02% | 677 |
|
|
2016
Q1 | $227K | Sell |
273
-20
| -7% | -$15.9K | 0.04% | 540 |
|
|
2015
Q4 | $307K | Sell |
293
-426
| -59% | -$427K | 0.06% | 393 |
|
|
2015
Q3 | $564K | Sell |
719
-57
| -7% | -$58.5K | 0.11% | 199 |
|
|
2015
Q2 | $1.02M | Buy |
776
+391
| +102% | +$631K | 0.19% | 122 |
|
|
2015
Q1 | $783K | Buy |
+385
| New | +$837K | 0.13% | 171 |
|
Other funds holding RGLS
NMC
BI
SCM
CH
TRCT
